Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study
13 affiliations
- 1Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 2Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland
- 3Pediatric Research Center, New Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
- 4Department of Virology, Medicum, University of Helsinki, Helsinki, Finland
- 5Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland
- 6Biostatistics Consulting, Department of Public Health, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 7Erzurum Technical University, Erzurum, Turkey
- 8Virology and Immunology, Helsinki University Hospital Diagnostic Center, Helsinki, Finland
- 9Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland
- 10Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University and Tampere University Hospital, Tampere, Finland
- 11Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland
- 12Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland
- 13Turku, Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
Abstract
Background: While COVID-19 lockdowns have been systematically associated with increased incidence rate of type 1 diabetes, less is known about the disease rates after lockdowns. We compared the incidence of type 1 diabetes after the COVID-19 pandemic-related closure of society (i) to the time when lockdown was implemented and to (ii) the time before the pandemic in Finland. Methods and findings: The incidence of type 1 diabetes after the lockdown (09/2021–12/2022) was compared to the incidence during the lockdown (03/2020–08/2021) and before the lockdown (three 18-month terms 2014–2019) in Finnish children under the age of 15 years. Previous exposure to SARS-CoV-2 was identified by combining information on COVID-19 vaccination with data on SARS-CoV-2 antibodies analyzed in blood samples. The temporal cohort included 3,467 pediatric type 1 diabetes cases, distributed across post-lockdown (n = 586), lockdown (n = 785), and pre-pandemic (n = 2,096) periods. The incidence of type 1 diabetes after the lockdown was significantly lower than the incidence during the lockdown [incidence rate ratio (IRR = 0.85; 95% Cl [0.77,0.95]; p = 0.004)]. The rate of type 1 diabetes after the lockdown did not significantly differ from the time before lockdown (IRR = 1.00; 95% Cl [0.91,1.09]; p = 0.932). The frequency of children testing positive for infection-associated SARS-CoV-2 antibodies increased from 0.9% during the lockdown to more than 40% after the lockdown. Study limitations include a relatively short follow-up period after the lockdown and the lack of explicit modeling of the underlying long-term secular trend in type 1 diabetes incidence. Conclusions: The lockdown represents a peak in childhood type 1 diabetes incidence in Finland compared to both the pre-pandemic and post-lockdown periods. However, the reversion toward historical levels after the lockdown does not necessarily establish a return to the expected historical trajectory, nor can it fully distinguish a transient change from temporal compensation superimposed on the background secular trend. The contrasting patterns between type 1 diabetes incidence and SARS-CoV-2 antibody prevalence during and after the lockdown suggest an indirect rather than a direct role of the virus in triggering the observed changes in incidence. Why was this study done?: What did the researchers do and find?: What do these findings mean?: In this observational study, Susanna Tall and colleagues found that childhood type 1 diabetes incidence declined in Finland after COVID-19 lockdown restrictions ended, returning to levels comparable with those observed before the pandemic. Their findings suggest that the elevated incidence seen during the lockdown period represented a temporary peak.
Related
- Tooth wear and socioeconomic status in childhood and adulthood: Findings from a systematic review and meta-analysis of observational studies
- The Enigma of Finnish and Sardinian Type 1 Diabetes Incidence: Where Population History Meets Genetics
- Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment
- Depressive symptoms are associated with the incidence of frailty in older adults with cardiometabolic diseases: Interaction between depression and diabetes
- Higher intake of dietary dicarbonyl compounds is associated with lower incidence of type 2 diabetes: European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study
BibTeX
@article{tall2026trends,
title = {{Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study}},
author = {Susanna Tall and Maaret Turtinen and Anna Parviainen and Jenni Pettersson and Anna But and Taina Härkönen and Jussi Hepojoki and Tarja Sironen and Rommel Iheozor-Ejiofor and Hasan Uğurlu and Kalle Saksela and Jorma Ilonen and Suvi M. Virtanen and Olli Vapalahti and Mikael Knip and on behalf of the Finnish Pediatric Diabetes Register},
journal = {PLOS Medicine},
year = {2026},
month = nov,
doi = {10.1371/journal.pmed.1005288},
url = {https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005288},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study
AU - Susanna Tall
AU - Maaret Turtinen
AU - Anna Parviainen
AU - Jenni Pettersson
AU - Anna But
AU - Taina Härkönen
AU - Jussi Hepojoki
AU - Tarja Sironen
AU - Rommel Iheozor-Ejiofor
AU - Hasan Uğurlu
AU - Kalle Saksela
AU - Jorma Ilonen
AU - Suvi M. Virtanen
AU - Olli Vapalahti
AU - Mikael Knip
AU - on behalf of the Finnish Pediatric Diabetes Register
PY - 2026
DA - 2026/11/02
JO - PLOS Medicine
DO - 10.1371/journal.pmed.1005288
UR - https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005288
AB - Background: While COVID-19 lockdowns have been systematically associated with increased incidence rate of type 1 diabetes, less is known about the disease rates after lockdowns. We compared the incidence of type 1 diabetes after the COVID-19 pandemic-related closure of society (i) to the time when lockdown was implemented and to (ii) the time before the pandemic in Finland. Methods and findings: The incidence of type 1 diabetes after the lockdown (09/2021–12/2022) was compared to the incidence during the lockdown (03/2020–08/2021) and before the lockdown (three 18-month terms 2014–2019) in Finnish children under the age of 15 years. Previous exposure to SARS-CoV-2 was identified by combining information on COVID-19 vaccination with data on SARS-CoV-2 antibodies analyzed in blood samples. The temporal cohort included 3,467 pediatric type 1 diabetes cases, distributed across post-lockdown (n = 586), lockdown (n = 785), and pre-pandemic (n = 2,096) periods. The incidence of type 1 diabetes after the lockdown was significantly lower than the incidence during the lockdown [incidence rate ratio (IRR = 0.85; 95% Cl [0.77,0.95]; p = 0.004)]. The rate of type 1 diabetes after the lockdown did not significantly differ from the time before lockdown (IRR = 1.00; 95% Cl [0.91,1.09]; p = 0.932). The frequency of children testing positive for infection-associated SARS-CoV-2 antibodies increased from 0.9% during the lockdown to more than 40% after the lockdown. Study limitations include a relatively short follow-up period after the lockdown and the lack of explicit modeling of the underlying long-term secular trend in type 1 diabetes incidence. Conclusions: The lockdown represents a peak in childhood type 1 diabetes incidence in Finland compared to both the pre-pandemic and post-lockdown periods. However, the reversion toward historical levels after the lockdown does not necessarily establish a return to the expected historical trajectory, nor can it fully distinguish a transient change from temporal compensation superimposed on the background secular trend. The contrasting patterns between type 1 diabetes incidence and SARS-CoV-2 antibody prevalence during and after the lockdown suggest an indirect rather than a direct role of the virus in triggering the observed changes in incidence. Why was this study done?: What did the researchers do and find?: What do these findings mean?: In this observational study, Susanna Tall and colleagues found that childhood type 1 diabetes incidence declined in Finland after COVID-19 lockdown restrictions ended, returning to levels comparable with those observed before the pandemic. Their findings suggest that the elevated incidence seen during the lockdown period represented a temporary peak.
SN - 1549-1676
ER -